A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Pleurocidin-like peptide GcSc4C5 | Pleurocidin-like peptide GcSc4C5 is an antibacterial peptide isolated from Glyptocephalus cynoglossus. It has activity against gram-positive bacteria, gram-negative bacteria and fungi. Synonyms: Ala-Gly-Trp-Gly-Ser-Ile-Phe-Lys-His-Ile-Phe-Lys-Ala-Gly-Lys-Phe-Ile-His-Gly-Ala-Ile-Gln-Ala-His-Asn-Asp-NH2; Witch flounder GcSc4C5; NRC-14. Grades: >96%. Molecular formula: C134H197N39O31. Mole weight: 2850.29. |  |
| Pleurocidin-like peptide Hb18 | Pleurocidin-like peptide Hb18 is an antibacterial peptide isolated from Hippoglossus hippoglossus. It has activity against gram-positive bacteria, gram-negative bacteria and fungi. Synonyms: Gly-Phe-Leu-Gly-Ile-Leu-Phe-His-Gly-Val-His-His-Gly-Arg-Lys-Lys-Ala-Leu-His-Met-Asn-Ser-Glu-Arg-Arg-Ser-NH2; Halibut Hb18; NRC-20. Grades: >97%. Molecular formula: C132H211N47O31S. Mole weight: 2984.50. | |
| Pleurocidin-like peptide Hb26 | Pleurocidin-like peptide Hb26 is an antibacterial peptide isolated from Hippoglossus hippoglossus. It has activity against gram-positive bacteria, gram-negative bacteria and fungi. Synonyms: Phe-Leu-Gly-Leu-Leu-Phe-His-Gly-Val-His-His-Val-Gly-Lys-Trp-Ile-His-Gly-Leu-Ile-His-Gly-His-His-NH2; Halibut Hb26; NRC-19. Molecular formula: C133H191N41O24. Mole weight: 2748.25. | |
| Pleurocidin-like peptide WFX | Pleurocidin-like peptide WFX is an antibacterial peptide isolated from Pseudopleuronectes americanus. It has activity against gram-positive bacteria, gram-negative bacteria and fungi. Synonyms: Arg-Ser-Thr-Glu-Asp-Ile-Ile-Lys-Ser-Ile-Ser-Gly-Gly-Gly-Phe-Leu-Asn-Ala-Met-Asn-Ala-NH2. Molecular formula: C92H154N28O31S. Mole weight: 2180.47. | |
| Pleurocidin-like peptide YT2 | Pleurocidin-like peptide YT2 is an antibacterial peptide isolated from Limanda ferruginea. It has activity against gram-positive bacteria, gram-negative bacteria and fungi. Synonyms: Arg-Trp-Gly-Lys-Trp-Phe-Lys-Lys-Ala-Thr-His-Val-Gly-Lys-His-Val-Gly-Lys-Ala-Ala-Leu-Thr-Ala-Tyr-Leu-NH2; NRC-07; Yellowtail flounder YT2. Molecular formula: C136H210N40O28. Mole weight: 2853.43. | |
| Pleuromutilin | ?95%. Group: Fluorescence/luminescence spectroscopypharmaceutical toxicology. Alternative Names: Tiamulin Hydrogen Fumarate Imp. G, Tiamulin Imp. G (EP), Valnemulin Imp. E (EP), Pleuromutilin,Tiamulin Hydrogen Fumarate Imp. G (EP), (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-Ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopentacycloocten-8-yl Hydroxyacetate, Retapamulin related. |  |
| Pleuromutilin | Pleuromutilin (Drosophilin B) exhibits antibacterial activity through inhibition of protein synthesis [1]. Uses: Scientific research. Group: Natural products. Alternative Names: Drosophilin B; Mutilin 14-glycolate. CAS No. 125-65-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 500 mg. Product ID: HY-N2301. |  |
| Pleuromutilin | Antibiotic substance produced by the basidiomycetes Pleurotus mutilus. Group: Biochemicals. Alternative Names: 2-Hydroxyacetic Acid (3aS, 4R, 5S, 6S, 8R, 9R, 9aR, 10R)-6-ethenyldecahydro-5-hydroxy-4, 6, 9, 10-tetramethyl-1-oxo-3a, 9-propano-3aH-cyclopentacycloocten-8-yl Ester; Pleuromulin. Grades: Highly Purified. CAS No. 125-65-5. Pack Sizes: 5mg. US Biological Life Sciences. |  Worldwide |
| Pleuromutilin | It is produced by the strain of Drosophila subatrata. It is mainly anti-gram-positive bacterial activity. Synonyms: Drosophilin B; Drosopholin B; Mutilin 14-glycolate; (3aR,4R,5R,7S,8S,9R,9aS,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-hydroxyacetate; Valnemulin impurity E; Glycolic acid, 8-dihydroxy-4,6,9,10-tetramethyl-6-vinyl-3a,9-propano-3aH-cyclopentacycloocten-1(4H)-one; antibiotic bc757. Grades: >95%. CAS No. 125-65-5. Molecular formula: C22H34O5. Mole weight: 378.50. | |
| Pleuromutilin 22-Mesylate | Pleuromutilin 22-Mesylate is a derivative of Pleuromutilin, which is an antibiotic produced by the basidiomycetes Pleurotus mutilus and used for the synthesis of Retapamulin. Synonyms: [3aS-(3aα, 4β, 5α, 6α, 8β, 9α, 9aβ, 10S*)]-6-Ethenyldecahydro-5-hydroxy-4, 6, 9, 10-tetramethyl-1-oxo-3a, 9-propano-3aH-cyclopentacycloocten-8-yl Ester [(Methylsulfonyl)oxy]acetic Acid; 3a,9-Propano-3aH-cyclopentacyclooctene, acetic acid deriv; pleuromutilin methanesulfonate; pleuromutilin mesylate; PLM-mesylate; 2-[(Methylsulfonyl)oxy]acetic acid (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester. Grades: ≥95%. CAS No. 60924-38-1. Molecular formula: C23H36O7S. Mole weight: 456.59. | |
| Pleuromutilin (Drosophilin B, Antibiotic A 40104C) | Pleuromutilin is a diterpene produced by several species of basidomycetes, notably the genus Pleurotus, discovered in 1951. Pleuromutilin is a potent and highly selective antibiotic active against a range of Gram positive bacteria with no cross resistance to existing antibiotic classes due to its unique mode of action. Pleuromutilin inhibits protein synthesis by binding to domain V of 23S rRNA and this has led to the development of many semi-synthetic analogues as new generation antibiotics, such as tiamulin and retapamulin. Group: Biochemicals. Grades: Highly Purified. CAS No. 125-65-5. Pack Sizes: 25mg. US Biological Life Sciences. | Worldwide |
| Pleurostatin | Pleurostatin is an antibacterial peptide isolated from Pleurotus ostreatus (Oyster mushroom). It has activity against fungi. Synonyms: Val-Arg-Pro-Tyr-Leu-Val-Ala-Phe. Grades: >95%. Molecular formula: C48H73N11O10. Mole weight: 964.18. | |
| Plevitrexed | Plevitrexed is an orally bioavailable, small molecule, non-polyglutamatable, antifolate quinazoline derivative thymidine synthetase inhibitor with potential antineoplastic activity. Plevitrexed is transported into the cell via the physiological reduced folate carrier (RFC) system. Intracellularly, this agent selectively binds to the folate binding site of thymidylate synthase and inhibits thymidine synthesis, which may result in DNA synthesis inhibition and apoptosis. Uses: Antineoplastic agents. Synonyms: ZD 9331; BGC9331; (αS)-α-[[4-[[(1,4-Dihydro-2,7-dimethyl-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]-2-fluorobenzoyl]amino]-1H-tetrazole-5-butanoic Acid; NSC 696259; Vamidex; (2S)-2-((4-(((2,7-Dimethyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl)(prop-2-ynyl)amino)-2-fluorobenzoyl)amino)-4-(1H-tetrazol-5-yl)butanoic acid. Grades: ≥95%. CAS No. 153537-73-6. Molecular formula: C26H25FN8O4. Mole weight: 532.53. | |
| PLGA (50:50) | PLGA (50:50) (poly(lactic-co-glycolic acid) (50:50)) is a copolymer of poly lactic acid (PLA) and poly glycolic acid (PGA) which can be used to fabricate devices for drug delivery and tissue engineering applications. Uses: Scientific research. Group: Biochemical assay reagents. Alternative Names: poly(lactic-co-glycolic acid) (50:50). CAS No. 34346-01-5. Pack Sizes: 500 mg; 1 g. Product ID: HY-B2247. | |
| PLGA (75:25) | PLGA (75:25) is a low toxicity, biocompatible and biodegradable controlled drug delivery carrier, can achieve slow release in the organism. PLGA (75:25) is a copolymer of 75% poly lactic acid (PLA) and 25% poly glycolic acid (PGA). PLGA (75:25) has been extensively studied as delivery vehicles for agents, proteins and various other macromolecules such as DNA, RNA and peptides[1][2][3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: poly(lactic-co-glycolic acid) (75:25). CAS No. 34346-01-5. Pack Sizes: 100 mg; 500 mg. Product ID: HY-B2247A. | |
| PLGA-b-PPEEA | PLGA has good biocompatibility and biodegradability,and is non-toxic.It can also be used as a carrier of protein and enzyme drugs. Synonyms: Poly(lactic-co-glycolic acid)-b-PPEEA. Product ID: MSMN-060. Category: Raw Materials. |  |
| PLGA-dialcohol | Block copolymer micelles are core-shell polymer micelles spontaneously formed by amphiphilic block copolymers dissolved in water to solubilize and encapsulate drugs. Most of the carriers are synthetic,biodegradable and thermodynamically stable in aqueous media. Synonyms: poly(L-lactide-co-glycolide)-dialcohol. Product ID: MSMN-059. Category: Raw Materials. | |
| PLGA-fluorescein | Fluorescein labeled poly(L-lactide-co-glycolide) (PLGA-FITC, PLGA-Fluorescein) can be used to prepare fluorescent nanoparticles. Synonyms: Poly(lactide-co-glycolide)-fluorescein. Product ID: MSMN-073. Category: Raw Materials. | |
| PLGA microsphere excipient | PLGA microspheres are a biodegradable polymer with excellent biocompatibility, non-toxicity, and ability to form membranes and capsules. CAS No. 26780-50-7. Product ID: PE-0678. Product Keywords: Excipients; PE-0678; PLGA microsphere excipient; 26780-50-7. Grade: Pharmaceutical grade. Source and Preparation: PLGA microspheres are a biodegradable polymer with excellent biocompatibility, non-toxicity, and ability to form membranes and capsules. They are widely used in drug delivery systems, drug-release systems, and tissue engineering scaffolds for medical devices, as well as biodegradable surgical sutures, anti-adhesion membranes, and tissue engineering scaffolds. | |
| PLGA microspheres | PLGA microspheres. Group: Biodegradable polymers. |  |
| PLGA Microspheres-10 μm | Particles made of poly(D,L-lactide-co-glycolide) L/G ratio of 50/50, inherent viscosity of ~0.45 dL/gTo re-constitute: Warm to ambient temperature; Add DI water or buffer to achieve desired concentration; Vortex and sonicate for 5 minutes to ensure particles are well suspended. Synonyms: PLGA Nanoparticles. Product ID: MSMN-004. Category: Polymer Microspheres. | |
| PLGA Microspheres-1 μm | Particles made of poly(D,L-lactide-co-glycolide) L/G ratio of 50/50, inherent viscosity of ~0.45 dL/gTo re-constitute: Warm to ambient temperature; Add DI water or buffer to achieve desired concentration; Vortex and sonicate for 5 minutes to ensure particles are well suspended. Synonyms: PLGA Nanoparticles. Product ID: MSMN-001. Category: Polymer Microspheres. | |
| PLGA Microspheres-20 μm | Particles made of poly(D,L-lactide-co-glycolide) L/G ratio of 50/50, inherent viscosity of ~0.45 dL/gTo re-constitute: Warm to ambient temperature; Add DI water or buffer to achieve desired concentration; Vortex and sonicate for 5 minutes to ensure particles are well suspended. Synonyms: PLGA Nanoparticles. Product ID: MSMN-005. Category: Polymer Microspheres. | |
| PLGA Microspheres-25 μm | PLGA Microspheres-25 μm. Synonyms: PLGA Nanoparticles. Product ID: MSMN-006. Category: Polymer Microspheres. | |
| PLGA Microspheres-2 μm | To re-constitute: Remove the product from freezer.Wait until temperature rises to the ambient temperature.Add DI water or buffer to the container. Vortex and sonicate for 5 minutes to ensure the microspheres are well suspended. Synonyms: PLGA Nanoparticles. Product ID: MSMN-002. Category: Polymer Microspheres. | |
| PLGA Microspheres-30 μm | Particles made of poly(D,L-lactide-co-glycolide) L/G ratio of 50/50, inherent viscosity of ~0.45 dL/gTo re-constitute: Warm to ambient temperature; Add DI water or buffer to achieve desired concentration; Vortex and sonicate for 5 minutes to ensure particles are well suspended. Synonyms: PLGA Nanoparticles. Product ID: MSMN-007. Category: Polymer Microspheres. | |
| PLGA Microspheres-40 μm | Particles made of poly(D,L-lactide-co-glycolide) L/G ratio of 50/50, inherent viscosity of ~0.45 dL/gTo re-constitute: Warm to ambient temperature; Add DI water or buffer to achieve desired concentration; Vortex and sonicate for 5 minutes to ensure particles are well suspended. Synonyms: PLGA Nanoparticles. Product ID: MSMN-008. Category: Polymer Microspheres. | |
| PLGA Microspheres-50 μm | PLGA Microspheres-50 μm. Synonyms: PLGA Nanoparticles. Product ID: MSMN-009. Category: Polymer Microspheres. | |
| PLGA Microspheres-5 μm | Particles made of poly(D,L-lactide-co-glycolide) L/G ratio of 50/50, inherent viscosity of ~0.45 dL/gTo re-constitute: Warm to ambient temperature; Add DI water or buffer to achieve desired concentration; Vortex and sonicate for 5 minutes to ensure particles are well suspended. Synonyms: PLGA Nanoparticles. Product ID: MSMN-003. Category: Polymer Microspheres. | |
| PLGA nanoparticles | PLGA nanoparticles. Group: Biodegradable polymers. | |
| PLGA nanoparticles | 100 nm average diameter. Group: Biodegradable polymers. | |
| PLGA nanoparticles | 500 nm average diameter. Group: Biodegradable polymers. | |
| PLGA-PEG-COOH | PLGA-PEG-COOH, Poly(L-lactide-co-glycolide)-Polyethyleneglycol-carboxyl is a biodegradable functional amphiphilic block copolymer for drug delivery. PLGA-PEG-COOH can conjugate with peptides, antibodies, proteinsand others which contain amine groups on the surface. Synonyms: Poly(L-lactide-co-glycolide)-Polyethylene glycol-carboxyl. Product ID: MSMN-051. Category: Raw Materials. | |
| PLGA-PEG-NH2 | PLGA-PEG-NH2, Poly(L-lactide-co-glycolide)-Polyethyleneglycol-amine is one of the most commonly used biodegradable ABC polymers for drug delivery. Synonyms: Poly(L-lactide-co-glycolide)-Polyethylene glycol-amine. Product ID: MSMN-052. Category: Raw Materials. | |
| PLGA-PEG-PLGA (Mn (1000-1000-1000)) | PLGA-PEG-PLGA is an amphiphilic triblock copolymer which can self-assemble into micelles in aqueous medium due to the hydrophobic interactions present in the hydrophobic segments. The PEG segment imparts hydrophilicity and improves the biocompatibility of the copolymer. The PLGA segment forms a hydrophobic core and can solubilize hydrophobic drugs. These copolymers are widely used as nanocarriers for the sustained release of drugs. Synonyms: Poly(lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly(lactide-co-glycolide). Product ID: MSMN-069. Category: Raw Materials. | |
| PLGA-PEG-PLGA (Mn (1100-1000-1100)) | PLGA-PEG-PLGA is an amphiphilic triblock copolymer which can self-assemble into micelles in aqueous medium due to the hydrophobic interactions present in the hydrophobic segments. The PEG segment imparts hydrophilicity and improves the biocompatibility of the copolymer. The PLGA segment forms a hydrophobic core and can solubilize hydrophobic drugs. These copolymers are widely used as nanocarriers for the sustained release of drugs. Synonyms: Poly(lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly(lactide-co-glycolide). Product ID: MSMN-068. Category: Raw Materials. | |
| PLGA-PEG-PLGA (Mn (1,600-1,500-1,600)) | PLGA-PEG-PLGA (Mn (1,600-1,500-1,600)). Synonyms: Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide). Product ID: MSMN-070. Category: Raw Materials. | |
| PLGA-PEG-PLGA (Mn (1,700-1,500-1,700)) | PLGA-PEG-PLGA (Mn (1,700-1,500-1,700)). Synonyms: Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide). Product ID: MSMN-071. Category: Raw Materials. | |
| PLGF-1 human | recombinant, expressed in E. coli, ?95% (SDS-PAGE), ?95% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PLGF-2 human | recombinant, expressed in E. coli, ?90% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| PLGF-3 human | recombinant, expressed in E. coli, ?95% (SDS-PAGE), ?95% (HPLC), suitable for cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| PLGF from mouse | recombinant, expressed in E. coli, ?95% (SDS-PAGE), ?95% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| PLGF-I human | Animal-component free, recombinant, expressed in E. coli, ?95% (SDS-PAGE), ?95% (HPLC), suitable for cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| Plicamycin | Plicamycin (Mithramycin A) is a selective specificity protein 1 ( Sp1 ) inhibitor. Plicamycin inhibits the growth of various cancers by decreasing Sp1 protein. Plicamycin inhibits GSTM2 promoter activity and protein expression [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Mithramycin A. CAS No. 18378-89-7. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-A0122. | |
| Plicatol B | Plicatol B. Group: Biochemicals. CAS No. 108335-06-4. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Plicatol B | Plicatol B is a phenanthrene isolated from the stems of the orchid Flickingeria fimbriata. Synonyms: Moscatin; 4-methoxyphenanthrene-2,5-diol. Grades: >98%. CAS No. 108335-06-4. Molecular formula: C15H12O3. Mole weight: 240.258. | |
| Plicatone | Plicatone. CAS No. 41724-19-0. VIGON Item # 502831. Categories: Speciality Ingrdients Suppliers, Fragrances, Perfumers, herbal undecanone. |  America & Internationally |
| Plinabulin | Plinabulin (NPI-2358) is a vascular disrupting agen ( VDA ) against tubulin-depolymerizing with an IC 50 of 9.8 nM against HT-29 cells [1]. Plinabulin binds the colchicine binding site of β-tubulin preventing polymerization and has potent inhibitory to tumor cells [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: NPI-2358. CAS No. 714272-27-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-14444. | |
| Plinabulin | Plinabulin is a vascular disrupting agent (VDA) against tubulin-depolymerizing with IC50 value of 9.8~18 nM in tumor cells under the development of Nereus Pharmaceuticals. It can bind to the colchicine binding site of b-tubulin preventing polymerization and disrupting the cytoplasmic microtubule network. In Sep 2016, BeyondSpring Pharmaceuticals planed a phase II/III trial for Neutropenia. Phase I clinical trials for Solid tumours and Phase III clinical trials for Non-small cell lung cancer are on-going. Uses: Non-small cell lung cancer; neutropenia;solid tumours. Synonyms: NPI 2358; NPI2358; NPI-2358; Plinabulin; UNII-986FY7F8XR; (3Z,6Z)-3-benzylidene-6-[(5-tert-butyl-1H-imidazol-4-yl)methylidene]piperazine-2,5-dione. Grades: 98%. CAS No. 714272-27-2. Molecular formula: C19H20N4O2. Mole weight: 339.39. | |
| Plitidepsin | Plitidepsin. Uses: Designed for use in research and industrial production. Product Category: Coronavirus and Solid Tumor Clinical Raw Materials. CAS No. 137219-37-5. Purity: >98%. Product ID: ACM137219375. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Plitidepsin | Plitidepsin (Aplidine) is a potent anti-cancer agent by targeting eEF1A2 ( K D =80?nM) [1]. Plitidepsin possesses antiviral activity and is against SARS-CoV-2 with an IC 90 of 0.88 nM. Plitidepsin is usually used for multiple myeloma and advanced cancer research, and has the potential for COVID-19 research [1] [2]. Uses: Scientific research. Group: Peptides. Alternative Names: Aplidine; PM90001. CAS No. 137219-37-5. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-16050. | |
| Plitidepsin | Plitidepsin is a cyclic depsipeptide isolated from the marine tunicate Aplidium albicans. Plitidepsin shows potent anticancer activity against a large variety of cultured human cancer cells, inducing apoptosis by triggering mitochondrial cytochrome c release, initiating the Fas/DC95, JNK pathway and activating caspase 3 activation. This agent also inhibits elongation factor 1-a, thereby interfering with protein synthesis, and induces G1 arrest and G2 blockade, thereby inhibiting tumor cell growth. Synonyms: aplidin; aplidine; plitidepsin; dehydrodidemnin B. Grades: >98%. CAS No. 137219-37-5. Molecular formula: C57H87N7O15. Mole weight: 1110.34. | |
| Plixorafenib | PLX8394 is a potent and selective BRaf inhibitor, with an IC 50 of appr 5 nM for BRAF V600E. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PLX8394; FORE8394. CAS No. 1393466-87-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-18972. | |
| PLK1, active, His tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| PLK1 Polo Box Domain active human | recombinant, expressed in E. coli, ?90% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| PLK2 Active human | recombinant, expressed in baculovirus infected insect cells, ?60% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| PLK3, active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| PLK3 Active human | recombinant, expressed in baculovirus infected insect cells, ?80% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| PLK3 Polo Box Domain human | recombinant, expressed in E. coli, ?90% (SDS-PAGE). Group: Fluorescence/luminescence spectroscopy. | |
| PLK4, active, GST tagged human | recombinant, expressed in baculovirus infected Sf9 cells, ?70% (SDS-PAGE), buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| PLL coated Fe2O3 nanoparticles | PLL coated Fe2O3 nanoparticles. Group: Nanopowders. CAS No. 1317-61-9. | |
| PLN-1474 | PLN-1474 (compound 1) is an orally active and selective ???1 integrin inhibitor with an IC50 value of <50 nM. PLN-1474 reduces levels of pSMAD3/SMAD3 in liver, hepatic collagen gene expression and hepatic OHP concentration in liver fibrosis mouse model. PLN-1474 can be used for the research of preventing, delaying or researching a fibrotic or cirrhotic disease or disorder. Uses: Scientific research. Group: Signaling pathways. CAS No. 2408065-32-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-47888. | |
| PlnA-17 | PlnA-17 is an antibacterial peptide isolated from Lactobacillus plantarum. It has activity against gram-positive bacteria. Grades: >95%. Molecular formula: C97H153N25O20. Mole weight: 1989.44. | |
| PlnA-22 | PlnA-22 is an antibacterial peptide isolated from Lactobacillus plantarum. It has activity against gram-positive bacteria. Synonyms: Tyr-Ser-Leu-Gln-Met-Gly-Ala-Thr-Ala-Ile-Lys-Gln-Val-Lys-Lys-Leu-Phe-Lys-Lys-Trp-Gly-Trp. Grades: >97%. Molecular formula: C125H195N31O28S. Mole weight: 2612.17. | |
| Plogosertib | Plogosertib (CYC140) is a selective, potent, and orally active ATP-competitive PLK1 inhibitor (IC50: 3 nM). Plogosertib is an anti-cancer agent with anti-proliferative activity. Plogosertib can be used in the research of several tumors, including esophageal, gastric, leukemia, non-small cell lung cancer, ovarian, and squamous cell cancers[1][2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: CYC140. CAS No. 1137212-79-3. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-147298. | |
| Plozalizumab | Plozalizumab (MLN-1202) is a specific humanized anti- CCR2 antibody. Plozalizumab can be used for malignant melanoma research [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MLN-1202. CAS No. 1610761-46-0. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99781. | |
| PLP (139-151) | PLP (139-151) is amino acid residue 139 to 151 of myelin proteolipid protein (PLP) used to induce experimental autoimmune encephalomyelitis (EAE). Uses: Scientific research. Group: Peptides. CAS No. 131334-43-5. Pack Sizes: 5 mg. Product ID: HY-P0129. | |
| PLP (139-151) | PLP (139-151). Group: Biochemicals. Grades: Purified. CAS No. 122018-58-0. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| PLP 139-151 | PLP 139-151 is the 139-151 amino acid residue of myelin protein (PLP), used to induce experimental autoimmune encephalomyelitis (EAE). Synonyms: Myelin Proteolipid Protein (139-151) (depalmitoylated) (human, bovine, dog, mouse, rat); His-Cys-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe; L-histidyl-L-cysteinyl-L-leucyl-glycyl-L-lysyl-L-tryptophyl-L-leucyl-glycyl-L-histidyl-L-prolyl-L-alpha-aspartyl-L-lysyl-L-phenylalanine. Grades: >98%. CAS No. 131334-43-5. Molecular formula: C72H104N20O16S. Mole weight: 1537.79. | |
| PLP (180-199) TFA | PLP (180-199) TFA is the TFA salt form of PLP (180-199) (HY-P5462). PLP (180-199) TFA induces the activation and differentiation of T cells, and induces the experimental autoimmune encephalomyelitis (EAE) in mouse model[1]. Uses: Scientific research. Group: Peptides. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P5462A. | |
Our database is helping our users find suppliers everyday.
